Cover Image
市場調查報告書

體外受精 (IVF) 的全球市場 - 2014∼2021年的市場機會及市場預測

World In-vitro Fertilization (IVF) - Market Opportunities and Forecasts, 2014 - 2021

出版商 Allied Market Research 商品編碼 335323
出版日期 內容資訊 英文 254 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
體外受精 (IVF) 的全球市場 - 2014∼2021年的市場機會及市場預測 World In-vitro Fertilization (IVF) - Market Opportunities and Forecasts, 2014 - 2021
出版日期: 2015年06月01日 內容資訊: 英文 254 Pages
簡介

體外受精(IVF)醫療產業的出現,成了可望治療不孕症的最佳方法,受到胚胎著床前診斷(PGD)、三親受精試管嬰兒」IVF手術(粒線體轉殖IVF)等相關技術進步的影響,現在預測將會大幅成長。IVF全球市場預測在2015年到2021年間將以年複合成長率(CAGR)7.0%的速度持續擴大,到2021年達到113億美金的市場規模。

本報告詳查IVF的全球市場,提供您推動市場成長要素,阻礙因素,市場機會,以及法律規章和保險制度等市場環境之詳細驗証,目前的市場方案分析與到2021年前的市場預測。這份報告不僅提供北美,歐洲,亞太地區,以及南美·中東·非洲地區等各地區市場分析,更提供各地區主要國家之各國詳細市場分析以及市場預測。還有市場分析中的主要企業之詳細企業簡介。

第1章 序論

  • 關於本報告
  • 主要的成果
  • 主要市場領域
  • 調查手法

第2章 摘要整理

第3章 體外受精 (IVF) 全球市場概要

  • 市場定義及範圍
  • 各國IVF價格趨勢
  • 各國IVF循環
  • 終端用戶別IVF全球市場
  • 市場動態
    • 推動市場成長要素
      • 女性妊娠時期的延遲
      • 全球性不孕率的上升
      • 新人工授精旅遊目的地的出現
    • 阻礙市場成長要素
      • 治療相關成本
      • 新興經濟圈的認知度低
      • 對IVF治療的保險給付制度不足
      • 倫理性的考慮
    • 市場機會
      • 法律上限制放寬促成的市場成長
      • 新技術的開發與新治療選擇
      • 三親受精試管嬰兒IVF (粒線體轉殖IVF)
  • 重要的調查結果

第4章 北美的IVF市場

  • 美國IVF市場 (收益及循環數)
    • 循環數 - 2014∼2021年
    • 美國IVF市場 - 2014∼2021年
    • 不孕治療診所數 - 2014年
  • 終端用戶別美國IVF市場
    • 市場動態
      • 推動市場成長要素
      • 阻礙市場成長要素
    • 法制問題,法規,法規當局
    • 保險給付方案
    • 企業簡介
  • 加拿大IVF市場 (收益及循環數)
  • 終端用戶別加拿大IVF市場
  • 墨西哥IVF市場 (收益及循環數)
  • 終端用戶別墨西哥IVF市場

第5章 歐洲IVF市場 (收益及循環數)

  • 德國IVF市場 (收益及循環數)
  • 終端用戶別德國IVF市場
  • 法國IVF市場 (收益及循環數)
  • 終端用戶別法國IVF市場
  • 英國IVF市場 (收益及循環數)
  • 終端用戶別英國IVF市場
  • 義大利IVF市場 (收益及循環數)
  • 終端用戶別義大利IVF市場
  • 西班牙IVF市場 (收益及循環數)
  • 終端用戶別西班牙IVF市場
  • 丹麥IVF市場 (收益及循環數)
  • 終端用戶別丹麥IVF市場
  • 俄羅斯IVF市場 (收益及循環數)
  • 終端用戶別俄羅斯IVF市場
  • 其他歐洲各國的IVF市場 (收益及循環數)
  • 按其他歐洲各國的終端用戶IVF市場

第6章 亞太地區IVF市場 (收益及循環數)

  • 印度IVF市場 (收益及循環數)
  • 終端用戶別印度IVF市場
  • 中國IVF市場 (收益及循環數)
  • 終端用戶別中國IVF市場
  • 日本IVF市場 (收益及循環數)
  • 終端用戶別日本IVF市場
  • 澳洲IVF市場 (收益及循環數)
  • 終端用戶別澳洲IVF市場
  • 紐西蘭IVF市場 (收益及循環數)
  • 終端用戶別紐西蘭IVF市場
  • 韓國IVF市場 (收益及循環數)
  • 終端用戶別韓國IVF市場
  • 泰國IVF市場 (收益及循環數)
  • 終端用戶別並列IVF市場
  • 其他的亞太地區各國的IVF市場 (收益及循環數)
  • 按其他的亞太地區各國的終端用戶IVF市場

第7章 南美,中東,及非洲地區IVF市場 (收益及循環數)

  • 南美IVF市場 (收益及循環數)
  • 終端用戶別南美IVF市場
  • 中東地區IVF市場 (收益及循環數)
  • 終端用戶別中東地區IVF市場
  • 非洲地區IVF市場 (收益及循環數)
  • 終端用戶別非洲地區IVF市場
目錄
Product Code: LI 15678

Title: Wprld In-vitro Fertilization (IVF) Services Market by End Users (Fertility Clinics, Hospitals, Surgical centers, Clinical research institutes)- Global Opportunity Analysis and Industry Forecast, 2014 - 2021.

IVF procedures have emerged as a preferable choice for the fertility treatments in clinical industry. The market is poised to witness a remarkable growth, primarily due to the related technological advancements such as pre-implantation genetic diagnosis (PGD) and three-parent IVF procedures.

The global IVF market is expected to reach $11.3 billion by 2021, at a CAGR of 7.0% from 2015 to 2021. Reduction in conception rates mainly in women aged 40 years or above, delayed pregnancy in women suffering from gynecological conditions, changing lifestyle and fertility disorders are the major factors that drive the market growth. Other factors responsible for the market growth are favorable reimbursement scenario and the delayed parenthood opted by couples due to professional and financial constraints. On the other hand, ethical concerns in particular countries, high cost of the IVF procedures and low awareness, especially in under-developed economies such as Nigeria are likely to restrain the market growth.

The rising initiatives towards commercialization of cost-efficient treatments and emerging medical tourism, mainly in developing nations would offer lucrative growth opportunities for IVF service providers in future. Further, the growing clinical research initiatives for the development of novel IVF technologies would provide a platform for growth of the global IVF market.

To provide a detailed market assessment, the report segments the global IVF market on the basis of end-users and geography. The end-users IVF market is categorized into fertility clinics, hospitals, surgical centres and clinical research institutes. Fertility clinics and hospitals were the leading end-user segments globally, accounting for around three-fourths of the market in 2014.

Geographically, the market is segmented across North America, Europe, Asia Pacific and LAMEA regions. In terms of number of IVF cycles performed, the Asia-Pacific region dominates the global IVF market. Asia Pacific IVF market is set to grow at a promising CAGR of 8.9% from 2015 to 2021, due to the factors such as wide availability of IVF clinics, high IVF success rates and the rising trend of fertility tourism. In Asia-Pacific region, China is the leading country accounting for majority of the market share and is expected to maintain its position during the analysis period. In terms of revenue, North America dominates the global IVF market, owing to the favorable reimbursement scenario. The market is expected to reach around $4.0 billion by 2021, at a CAGR of 7.9% over the forecast period.

KEY MARKET BENEFITS:

  • The report provides an in-depth analysis of the IVF market across twenty major countries with a cross sectional analysis of the number of IVF cycles performed, and total revenue generated during the forecast period
  • The report helps in understanding the strategies adopted by various IVF clinics and hospitals in particular countries, in order to gain market share in the global IVF service market
  • Region-wise and country-wise IVF market is comprehensively analyzed in the report
  • The projections in the report are made by analyzing the current market trends and highlighting the market potential for the period of 2014-2021, in terms of value and volume
  • Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework

KEY MARKET SEGMENTS:

The global IVF market is segmented on the basis of end-users and geography:

Global IVF Market - By End Users (Value and Volume)

  • Fertility Clinics
  • Hospitals
  • Surgical centers
  • Clinical research institutes

Global IVF Market - By End User Country Level Analysis (Value and Volume)

  • United States
  • Canada
  • Mexico
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Russia
  • Others Europe
  • China
  • India
  • Japan
  • Australia
  • New Zealand
  • Korea
  • Thailand
  • Others APAC
  • Latin America
  • Middle East
  • Africa

Global IVF Market - By Geography (Value and Volume)

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Russia
    • Others Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • New Zealand
    • Korea
    • Thailand
    • Others APAC
  • LAMEA
    • Latin America
    • Middle East
    • Africa

Table of Contents

Chapter 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Benefits
  • 1.3. Key Market Segments
  • 1.4. Research Methodology
    • 1.4.1. Secondary research
    • 1.4.2. Primary research
    • 1.4.3. Analyst tools and models

Chapter 2: EXECUTIVE SUMMARY

Chapter 3: GLOBAL IN VITRO FERTILIZATION (IVF) MARKET OVERVIEW

  • 3.1. Market Definition and Scope
  • 3.2. IVF pricing trends by country
  • 3.3. IVF Cycles by Country
  • 3.4. Global IVF Market by End Users
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
      • 3.5.1.1. Delayed pregnancies in women
      • 3.5.1.2. Rise in global infertility rates
      • 3.5.1.3. Emergence of new fertility tourism destinations
    • 3.5.2. Restraints
      • 3.5.2.1. Cost involved in the treatment
      • 3.5.2.2. Low level of awareness in developing economies
      • 3.5.2.3. Inadequate reimbursements policies for IVF treatments
      • 3.5.2.4. Ethical Considerations
    • 3.5.3. Opportunities
      • 3.5.3.1. Market growth by relaxing the legal considerations
      • 3.5.3.2. New technology development and treatment options
      • 3.5.3.3. Three parent IVF
  • 3.6. Key Findings

Chapter 4: NORTH-AMERICA IVF MARKET

  • 4.1. United States IVF Market, (revenue and Number of Cycles)
    • 4.1.1. Number of IVF Cycles, 2014-2021
    • 4.1.2. United States IVF Market, 2014-2021 ($Million)
    • 4.1.3. Number of Infertility Clinics, 2014
  • 4.2. United States IVF Market by End Users
    • 4.2.1. Market Dynamics
      • 4.2.1.1. Drivers
        • 4.2.1.1.1. INCREASING POPULARITY OF IVF IN UNITED STATES
        • 4.2.1.1.2. INCREASED RATE OF INFERTILITY AND PRACTICES OF EMBRYO BANKING CYCLES
      • 4.2.1.2. Restraints
        • 4.2.1.2.1. HIGH COST OF IVF IN UNITED SATES
        • 4.2.1.2.2. BAN ON 3-PARENT IVF
        • 4.2.1.2.3. SCATTERED REIMBURSEMENTS
    • 4.2.2. Regulatory Issues, Legislations and Authorities
    • 4.2.3. Insurance Reimbursement Scenario
    • 4.2.4. Company Profile
      • 4.2.4.1. Fertility and Gynecology Center Monterey Bay IVF
      • 4.2.4.2. Conceptions Reproductive Associates
      • 4.2.4.3. Servy Massey Fertility Institute
      • 4.2.4.4. Sher Institute for Reproductive Medicine (SIRM)
      • 4.2.4.5. Cardone Reproductive Medicine & Infertility
      • 4.2.4.6. Fertility Center of San Antonio
      • 4.2.4.7. Houston Fertility Center
      • 4.2.4.8. New hope fertility center
      • 4.2.4.9. Reproductive Medicine Associates Of New Jersey
  • 4.3. Canada IVF Market (Revenue and Number of Cycles)
    • 4.3.1. Number of IVF Cycles, 2014-2021
    • 4.3.2. Canada IVF Market, 2014-2021 ($Million)
    • 4.3.3. Number of infertility centres
  • 4.4. Canada IVF Market by End users
    • 4.4.1. Market Dynamics
      • 4.4.1.1. Drivers
        • 4.4.1.1.1. COMMERCIALIZATION OF IVF BOOSTER IN CANADA
      • 4.4.1.2. Restraints
        • 4.4.1.2.1. HIGH COST OF IVF IN CANADA
    • 4.4.2. Regulatory Issues, Legislations and Authorities
    • 4.4.3. Insurance Reimbursement Scenario
    • 4.4.4. Company Profile
      • 4.4.4.1. Toronto Centre for Advanced Reproductive Technology Ltd.
      • 4.4.4.2. Fertility Treatment Center
      • 4.4.4.3. Montreal Fertility Center
  • 4.5. Mexico IVF Market (Revenue and Number of Cycles)
    • 4.5.1. Number of IVF Cycles, 2014-2021
    • 4.5.2. Mexico IVF Market, 2014-2021 ($Million)
    • 4.5.3. Number of infertility centres
  • 4.6. Mexico IVF Market by End Users
    • 4.6.1. Market Dynamics
      • 4.6.1.1. Drivers
        • 4.6.1.1.1. FERTILITY TOURISM
        • 4.6.1.1.2. COMPARATIVELY LOW COST OF IVF
      • 4.6.1.2. Restraints
        • 4.6.1.2.1. LANGUAGE BARRIERS
    • 4.6.2. Regulatory Issues, Legislations and Authorities
    • 4.6.3. Insurance Reimbursement Scenario
    • 4.6.4. Company Profile
      • 4.6.4.1. Liv Fertility Center In Puerto Vallarta
      • 4.6.4.2. BFC Biofertility Center

    Chapter 5: EUROPE IVF MARKET (REVENUE AND NUMBER OF CYCLES)

    • 5.1. Germany IVF Market (Revenue and Number of Cycles)
      • 5.1.1. Number of IVF Cycles, 2014-2021
      • 5.1.2. Germany IVF Market, 2014-2021 ($Million)
      • 5.1.3. Number of infertility clinics
    • 5.2. Germany IVF Market by End Users
      • 5.2.1. Market Dynamics
        • 5.2.1.1. Drivers
          • 5.2.1.1.1. SUBSIDIZING IVF TREATMENTS
          • 5.2.1.1.2. DELAYED MARRIAGES AND PARENTHOOD DECISIONS
        • 5.2.1.2. Restraints
          • 5.2.1.2.1. STRINGENT GOVERNMENT REGULATIONS
          • 5.2.1.2.2. LACK OF AVAILABILITY IN TREATMENT CYCLES FOR IVF
      • 5.2.2. Regulatory Issues, Legislations and Authorities
      • 5.2.3. Insurance Reimbursement Scenario
      • 5.2.4. Company Profile
        • 5.2.4.1. Heidelberg University Hospital
        • 5.2.4.2. Klinikum Stuttgart
        • 5.2.4.3. DRK Kliniken Berlin
        • 5.2.4.4. University Medical Center Freiburg
    • 5.3. France IVF Market (Revenue and Number of Cycles)
      • 5.3.1. Number of IVF Cycles, 2014-2021
      • 5.3.2. France IVF Market, 2014-2021 ($Million)
      • 5.3.3. Number of infertility centers
    • 5.4. France IVF Market by End Users
      • 5.4.1. Market Dynamics
        • 5.4.1.1. Drivers
          • 5.4.1.1.1. SAME GENDER ADOPTION OF IVF BABIES
          • 5.4.1.1.2. LOWER RATES OF FERTILITY
        • 5.4.1.2. Restraints
          • 5.4.1.2.1. STRINGENT GOVERNMENT REGULATIONS
      • 5.4.2. Regulatory Issues, Legislations and Authorities
      • 5.4.3. Insurance Reimbursement Scenario
      • 5.4.4. Company Profile
        • 5.4.4.1. Clinique de la Muette
        • 5.4.4.2. Hopital des metallurgists, hopital cochin
    • 5.5. United Kingdom IVF Market (Revenue and Number of Cycles)
      • 5.5.1. Number of IVF Cycles, 2014-2021
      • 5.5.2. United Kingdom IVF Market, 2014-2021 ($Million)
      • 5.5.3. Number of infertility centers
    • 5.6. United Kingdom IVF Market by End Users
      • 5.6.1. Market Dynamics
        • 5.6.1.1. Drivers
          • 5.6.1.1.1. COMMERCIALIZATION OF THREE-PARENT IVF PROCEDURES
          • 5.6.1.1.2. SUPPORTIVE REGULATIONS
        • 5.6.1.2. Restraints
          • 5.6.1.2.1. ETHICAL CONSIDERATIONS
      • 5.6.2. Regulatory Issues, Legislations and Authorities
      • 5.6.3. Insurance Reimbursement Scenario
      • 5.6.4. Company Profile
        • 5.6.4.1. Lister Fertility Clinic
        • 5.6.4.2. The Bridge Center
        • 5.6.4.3. Chelsea and Westminster Hospital (Assisted Conception Unit)
    • 5.7. Italy IVF Market (Revenue and Number of Cycles)
      • 5.7.1. Number of IVF Cycles, 2014-2021
      • 5.7.2. Italy IVF Market, 2014-2021 ($Million)
    • 5.8. Italy IVF market by End users
      • 5.8.1. Market Dynamics
        • 5.8.1.1. Drivers
        • 5.8.1.2. Restraints
          • 5.8.1.2.1. BAN ON THE SURROGACY
      • 5.8.2. Regulatory issues, legislations and authorities
      • 5.8.3. Insurance Reimbursement Scenario
      • 5.8.4. Company Profile
        • 5.8.4.1. ARC-STER srl
        • 5.8.4.2. RAPRUI
        • 5.8.4.3. Centre for Reproductive Medicine-Napoli
    • 5.9. Spain IVF Market (Revenue and Number of Cycles)
      • 5.9.1. Number of IVF Cycles, 2014-2021
      • 5.9.2. Spain IVF Market, 2014-2021 ($Million)
    • 5.10. Spain IVF Market by End Users
      • 5.10.1. Market Dynamics
        • 5.10.1.1. Drivers
          • 5.10.1.1.1. INCREASE IN THE NUMBER OF FOREIGN PATIENTS
        • 5.10.1.2. Restraints
      • 5.10.2. Regulatory Issues, Legislations and Authorities
      • 5.10.3. Insurance Reimbursement Scenario
      • 5.10.4. Company Profiles
        • 5.10.4.1. IVF spain
        • 5.10.4.2. Clínica EUGIN Barcelona
    • 5.11. Denmark IVF Market (Revenue and Number Of Cycles)
      • 5.11.1. Number of IVF Cycles, 2014-2021
      • 5.11.2. Denmark IVF Market, 2014-2021 ($Million)
    • 5.12. Denmark IVF Market by End Users
      • 5.12.1. Market Dynamics
        • 5.12.1.1. Drivers
          • 5.12.1.1.1. INCREASE IN DISPOSABLE INCOME
          • 5.12.1.1.2. ADVANCES IN IVF TECHNOLOGY
        • 5.12.1.2. Restraints
          • 5.12.1.2.1. INADEQUATE REIMBURSEMENT POLICIES
      • 5.12.2. Regulatory Issues, Legislations and Authorities
      • 5.12.3. Insurance Reimbursement Scenario
      • 5.12.4. Company Profiles
        • 5.12.4.1. Copenhagen Fertility Center
        • 5.12.4.2. Storkklinik v/Nina Stork
        • 5.12.4.3. Vitanova
        • 5.12.4.4. trianglen fertility clinic
        • 5.12.4.5. Nordica - Denmark, Copenhagen
    • 5.13. Russia IVF Market (Revenue annd Number of Cycles)
      • 5.13.1. Number of IVF Cycles, 2014-2021
      • 5.13.2. Russia IVF Market, 2014-2021 ($Million)
    • 5.14. Russia IVF Market by End Users
      • 5.14.1. Market Dynamics
        • 5.14.1.1. Drivers
          • 5.14.1.1.1. RISING POPULARITY OF FERTILITY TOURISM
        • 5.14.1.2. Restraints
          • 5.14.1.2.1. INADEQUATE REIMBURSEMENT POLICIES
      • 5.14.2. Regulatory Issues, Legislations and Authorities
      • 5.14.3. Insurance Reimbursement Scenario
      • 5.14.4. Company Profiles
        • 5.14.4.1. ava-peter clinic
        • 5.14.4.2. md medical group
        • 5.14.4.3. ivf russia (The International Centre of the Reproductive Medicines)
    • 5.15. Other Europe IVF Market (Revenue and Number of Cycles)
      • 5.15.1. Number of IVF Cycles, 2014-2021
      • 5.15.2. Other Europe IVF Market, 2014-2021 ($Million)
    • 5.16. Other Europe IVF Market by End Users
      • 5.16.1. Market Dynamics
        • 5.16.1.1. Drivers
          • 5.16.1.1.1. WIDE AVAILABILITY OF REIMBURSEMENTS
          • 5.16.1.1.2. EMERGENCE OF NEW FERTILITY DESTINATIONS
          • 5.16.1.1.3. CHANGES IN LIFESTYLE
        • 5.16.1.2. Restraints
      • 5.16.2. Regulatory Issues, Legislations and Authorities
      • 5.16.3. Insurance Reimbursement Scenario
      • 5.16.4. Company Profiles
        • 5.16.4.1. Gynaecoloqisch Centrum
        • 5.16.4.2. centrum voor medische genetica
        • 5.16.4.3. Infertility-Väestöliitto

Chapter 6: ASIA-PACIFIC IVF MARKET (REVENUE AND NUMBER OF CYCLES)

  • 6.1. India IVF Market (Revenue and Number of Cycles)
    • 6.1.1. Number of IVF Cycles, 2014-2021
    • 6.1.2. India IVF Market, 2014-2021 ($Million)
  • 6.2. India IVF Market by End Users
    • 6.2.1. Market Dynamics
      • 6.2.1.1. Drivers
      • 6.2.1.2. Restraints
    • 6.2.2. Regulatory Issues, Legislations and Authorities
    • 6.2.3. Insurance Reimbursement Scenario
    • 6.2.4. Company Profile
      • 6.2.4.1. Sun Pharmaceutical
      • 6.2.4.2. Trivector Origio Scientific Pvt. Ltd
      • 6.2.4.3. LabIVF Asia Pte. Ltd
      • 6.2.4.4. LG Life Sciences.
      • 6.2.4.5. Cadila Healthcare Ltd.( Zydus Cadila group)
      • 6.2.4.6. Bourn Hall Clinic
      • 6.2.4.7. Southend Fertility and IVF Centre
      • 6.2.4.8. Morpheus IVF Fertility Center
      • 6.2.4.9. Bloom Fertility Center
      • 6.2.4.10. Manipal Ankur
      • 6.2.4.11. Cloudnine
      • 6.2.4.12. Nova IVI Fertility
  • 6.3. China IVF Market (revenue and number of cycles)
    • 6.3.1. Number of IVF Cycles, 2014-2021
    • 6.3.2. China IVF Market, 2014-2021 ($Million)
  • 6.4. China IVF Market by End User
    • 6.4.1. Market Dynamics
      • 6.4.1.1. Drivers
        • 6.4.1.1.1. INCREASED RATE OF INFERTILITY
        • 6.4.1.1.2. CHANGE IN LIFESTYLE
      • 6.4.1.2. Restraints
        • 6.4.1.2.1. COST OF LIVING
        • 6.4.1.2.2. ONE CHILD POLICY
    • 6.4.2. Regulatory Issues, Legislations and Authorities
    • 6.4.3. Insurance Reimbursement Scenario
    • 6.4.4. Company profile
      • 6.4.4.1. Cook Medical, Inc.
      • 6.4.4.2. Vitrolife AB
      • 6.4.4.3. Reproductive and genetic Hospital Citic-Xiangya
      • 6.4.4.4. Shenyang Hospital
      • 6.4.4.5. Shandong Provincial Hospital
      • 6.4.4.6. Centre for Reproductive Medicine
  • 6.5. Japan IVF Market (Revenue annd Number Of Cycles)
    • 6.5.1. Number of IVF Cycles, 2014-2021
    • 6.5.2. Japan IVF Market, 2014-2021 ($Million)
  • 6.6. Japan IVF Market by End-Users
    • 6.6.1. Market Dynamics
      • 6.6.1.1. Drivers
      • 6.6.1.2. Restraints
    • 6.6.2. Regulatory Issues, Legislations and Authorities
    • 6.6.3. Insurance Reimbursement Scenario
    • 6.6.4. Company Profile
      • 6.6.4.1. EMD Serono, Inc
      • 6.6.4.2. IVF NAMBA Clinic
      • 6.6.4.3. Iwaki Women's Clinic
      • 6.6.4.4. Sanno Hospital
  • 6.7. Australia IVF Market (Revenue annd Number Of Cycles)
    • 6.7.1. Number of IVF Cycles, 2014-2021
    • 6.7.2. Australia IVF Market, 2014-2021 ($Million)
  • 6.8. Australia IVF Market by End Users
    • 6.8.1. Market Dynamics
      • 6.8.1.1. Drivers
      • 6.8.1.2. Restraints
        • 6.8.1.2.1. EMOTIONAL AND PHYSICAL STRESS
        • 6.8.1.2.2. NO GUARANTEE FOR THE SUCCESSFUL TREATMENTS
        • 6.8.1.2.3. SURPLUS EMBRYOS
    • 6.8.2. Regulatory Issues, Legislations and Authorities
    • 6.8.3. Insurance Reimbursement Scenario
    • 6.8.4. Company Profile
      • 6.8.4.1. Genea Biomedx
      • 6.8.4.2. Thermo Fisher Scientific Inc.
      • 6.8.4.3. Virtus Health limited
      • 6.8.4.4. Monash IVF
      • 6.8.4.5. City Fertility center, brisbane
      • 6.8.4.6. Flinders Fertility clinic
  • 6.9. New Zealand IVF Market (Revenue and Number of Cycles)
    • 6.9.1. Number of IVF Cycles, 2014-2021
    • 6.9.2. New Zealand IVF Market, 2014-2021 ($Million)
  • 6.10. New Zealand IVF Market by End users
    • 6.10.1. Market Dynamics
      • 6.10.1.1. Drivers
      • 6.10.1.2. Restraints
    • 6.10.2. Regulatory Issues, Legislations and Authorities
    • 6.10.3. Insurance Reimbursement Scenario
    • 6.10.4. Company Profiles
      • 6.10.4.1. Fertility Associates
      • 6.10.4.2. Fertility Plus
      • 6.10.4.3. Repromed
  • 6.11. Korea IVF Market (Revenue and Number of Cycles)
    • 6.11.1. Number of IVF Cycles, 2014-2021
    • 6.11.2. Korea IVF Market, 2014-2021 ($Million)
  • 6.12. Korea IVF Market by End Users
    • 6.12.1. Market Dynamics
      • 6.12.1.1. Drivers
      • 6.12.1.2. Restraints
    • 6.12.2. Regulatory Issues, legislations and Authorities
    • 6.12.3. Insurance Reimbursement Scenario
    • 6.12.4. Company Profiles
      • 6.12.4.1. Cha General Hospital
      • 6.12.4.2. MARIA Fertility Hospital
  • 6.13. Thailand IVF Market (Revenue and number of Cycles)
    • 6.13.1. Number of IVF Cycles, 2014-2021
    • 6.13.2. Thailand IVF Market, 2014-2021 ($Million)
  • 6.14. Thailand IVF Market by End Users
    • 6.14.1. Market Dynamics
      • 6.14.1.1. Drivers
        • 6.14.1.1.1. GOVERNMENT INITIATIVES
        • 6.14.1.1.2. ECONOMICAL CONSIDERATIONS
        • 6.14.1.1.3. BOOST IN MEDICAL TOURISM
      • 6.14.1.2. Restraints
        • 6.14.1.2.1. COMPARATIVELY LOW SUCCESS RATE
        • 6.14.1.2.2. ETHICAL ISSUES IN ALLOWING GENDER SELECTION
    • 6.14.2. Regulatory Issues, legislations and Authorities
    • 6.14.3. Insurance Reimbursement Scenario
    • 6.14.4. Company Profiles
      • 6.14.4.1. Bangkok Fertility Center
      • 6.14.4.2. Siriraj Hospital
      • 6.14.4.3. Ramathibodi Hospital
      • 6.14.4.4. Perfect Woman Institute
      • 6.14.4.5. Jetanin Institute for Assisted Reproduction
  • 6.15. Other Asia-Pacific IVF Market (Revenue and Number of Cycles)
    • 6.15.1. Number of IVF Cycles, 2014-2021
    • 6.15.2. Other Asia-Pacific IVF Market, 2014-2021 ($Million)
  • 6.16. Other Asia-Pacific IVF Market by End Users
    • 6.16.1. Market Dynamics
      • 6.16.1.1. Drivers
        • 6.16.1.1.1. INCREASE IN DISPOSABLE INCOME
        • 6.16.1.1.2. ADVANCES IN IVF TECHNOLOGY
        • 6.16.1.1.3. DECLINE IN FERTILITY RATE
      • 6.16.1.2. Restraints
        • 6.16.1.2.1. PHYSICAL AND EMOTIONAL IMPACT DUE TO LOW SUCCESS RATE
    • 6.16.2. Regulatory Issues, legislations and Authorities
    • 6.16.3. Insurance Reimbursement Scenario
    • 6.16.4. Company Profiles
      • 6.16.4.1. Fertility Centre, Siloam Hospitals Surabana
      • 6.16.4.2. CRM-MIA-Philippines
      • 6.16.4.3. IVFAS

Chapter 7: LAMEA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

  • 7.1. Latin America IVF Market (Revenue and Number of Cycles)
    • 7.1.1. Number of IVF Cycles, 2014-2021
    • 7.1.2. Latin America IVF Market, 2014-2021 ($Million)
    • 7.1.3. Number of Infertility Centers
  • 7.2. Latin America IVF Market by End users
    • 7.2.1. Market Dynamics
      • 7.2.1.1. Drivers
        • 7.2.1.1.1. RISING MEDICAL TOURISM IN LATIN AMERICAN COUNTRIES
        • 7.2.1.1.2. LIFTED ITS BAN ON IVF TREATMENTS IN COUNTRIES SUCH AS COSTA RICA
      • 7.2.1.2. Restraints
        • 7.2.1.2.1. HIGH INFANT MORTALITY RATES IN BRAZIL
    • 7.2.2. Regulatory Issues, legislations and Authorities
    • 7.2.3. Insurance Reimbursement Scenario
    • 7.2.4. Profiles of Major Players
      • 7.2.4.1. Clinica Anglo Americana
      • 7.2.4.2. IVF Panama Centro De Reproduccion
      • 7.2.4.3. Insemer
      • 7.2.4.4. Almater Hospital
      • 7.2.4.5. San Fernando Hospital
  • 7.3. Middle East IVF Market (Revenue and Number of Cycles)
    • 7.3.1. Middle East IVF Market, 2014-2021 ($Million)
    • 7.3.2. Number of infertility centers
  • 7.4. Middle East IVF Market by End users
    • 7.4.1. Market Dynamics
      • 7.4.1.1. Drivers
        • 7.4.1.1.1. HIGH-TECH CULTURE IN THE MIDDLE EAST COUNTRIES
        • 7.4.1.1.2. WIDE AVAILABILITY OF REIMBURSEMENTS
      • 7.4.1.2. Restraints
        • 7.4.1.2.1. STRINGENT GOVERNMENT REGULATIONS IN MUSLIM MIDDLE EASTERN REGIONS
    • 7.4.2. Regulatory Issues, Legislations and Authorities
    • 7.4.3. Insurance Reimbursement Scenario
    • 7.4.4. Company Profile
      • 7.4.4.1. Cyprus IVF Centre
      • 7.4.4.2. Al Bushra Medical Specialty Complex
      • 7.4.4.3. Reproductive Medicine Unit at Corniche Hospital (Corniche Fertility center)
      • 7.4.4.4. Trakya University Hospital ART Center
  • 7.5. Africa IVF Market (Revenue and Number of Cycles)
    • 7.5.1. Number of IVF Cycles, 2014-2021
    • 7.5.2. Africa IVF Market, 2014-2021 ($Million)
    • 7.5.3. Number of infertility centers
  • 7.6. Africa IVF Market by End users
    • 7.6.1. Market Dynamics
      • 7.6.1.1. Drivers
        • 7.6.1.1.1. LOW IVF TREATMENT COSTS
        • 7.6.1.1.2. RISING FERTILITY TOURISM IN SOUTH AFRICA
      • 7.6.1.2. Restraints
        • 7.6.1.2.1. SUSCEPTIBILITY TOWARD FIBROIDS
    • 7.6.2. Regulatory Issues, legislations and Authorities
    • 7.6.3. Insurance Reimbursement Scenario
    • 7.6.4. Company Profile
      • 7.6.4.1. Lifesure Fertility & Gynaecology Centre
      • 7.6.4.2. Bethany Women and Family Hospital
      • 7.6.4.3. BioART Fertility Centre
      • 7.6.4.4. DEL International Hospital & Fertility Centre
      • 7.6.4.5. Gift ov life
      • 7.6.4.6. Durban Fertility Clinic
      • 7.6.4.7. Cape fertility clinic

List of Tables

  • TABLE 1: NUMBER OF IVF CYCLES BY REGION, 2014-2021 (THOUSAND)
  • TABLE 2: NUMBER OF IVF CYCLES BY REGION, 2014-2021 ($MILLION)
  • TABLE 3: PRICING TRENDS BY COUNTRY, 2014
  • TABLE 4: NUMBER OF IVF CYCLES BY COUNTRIES, 2014-2021 (THOUSAND)
  • TABLE 5: GLOBAL IVF CYCLES BY END USER, 2014 - 2021 (THOUSAND)
  • TABLE 6: GLOBAL IVF REVENUE BY END USER, 2014 - 2021 ($MILLION)
  • TABLE 7: IVF SUCCESS RATES ACCORDING TO AGE
  • TABLE 8: NORTH AMERICA IVF CYCLES, 2014 - 2021 (THOUSAND)
  • TABLE 9: NORTH AMERICA IVF MARKET 2014 - 2021 ($MILLION)
  • TABLE 10: FRESH EMBRYO TRANSFER FROM NON-DONOR OOCYTES, UNITED STATES, 2013
  • TABLE 11: THAWED EMBRYO TRANSFER FROM NON-DONOR OOCYTES, UNITED STATES, 2013
  • TABLE 12: DONOR OOCYTES (FOR ALL AGES), UNITED STATES, 2013
  • TABLE 13: UNITED STATES IVF CYCLES, 2014 - 2021 (THOUSAND)
  • TABLE 14: UNITED STATES IVF MARKET 2014 - 2021 ($MILLION)
  • TABLE 15: NUMBER OF FERTILITY CLINICS IN UNITED STATES (2014)
  • TABLE 16: UNITED STATES IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 17: UNITED STATES IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 18: FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF BUSINESS OVERVIEW
  • TABLE 19: SNAPSHOT OF FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY
  • TABLE 20: CONCEPTIONS REPRODUCTIVE ASSOCIATES BUSINESS OVERVIEW
  • TABLE 21: SNAPSHOT OF CONCEPTIONS REPRODUCTIVE ASSOCIATES
  • TABLE 22: SERVY MASSEY FERTILITY INSTITUTE BUSINESS OVERVIEW
  • TABLE 23: SNAPSHOT OF SERVY MASSEY FERTILITY INSTITUTE
  • TABLE 24: SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)BUSINESS OVERVIEW
  • TABLE 25: SNAPSHOT OF INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)
  • TABLE 26: CARDONE REPRODUCTIVE MEDICINE & INFERTILITY BUSINESS OVERVIEW
  • TABLE 27: SNAPSHOT OF CARDONE REPRODUCTIVE MEDICINE & INFERTILITY
  • TABLE 28: FERTILITY CENTER OF SAN ANTONIO BUSINESS OVERVIEW
  • TABLE 29: SNAPSHOT OF FERTILITY CENTER OF SAN ANTONIO
  • TABLE 30: HOUSTON FERTILITY CENTER BUSINESS OVERVIEW
  • TABLE 31: SNAPSHOT OF HOUSTON FERTILITY CENTER
  • TABLE 32: NEW HOPE FERTILITY CENTER BUSINESS OVERVIEW
  • TABLE 33: SNAPSHOT OF HOUSTON FERTILITY CENTER
  • TABLE 34: REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY BUSINESS OVERVIEW
  • TABLE 35: SNAPSHOT OF HOUSTON FERTILITY CENTER
  • TABLE 36: SUMMARY FOR IVF PROCEDURES, CANADA, 2012
  • TABLE 37: CYCLE OUTCOMES FOR IVF PROCEDURES, CANADA, 2012
  • TABLE 38: NUMBER OF IVF CYCLES, CANADA, 2014 - 2021 (THOUSAND)
  • TABLE 39: CANADA IVF MARKET 2014 - 2021 ($MILLION)
  • TABLE 40: CANADA IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 41: CANADA IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 42: BUSINESS OVERVIEW
  • TABLE 43: SNAPSHOT OF TORONTO CENTRE FOR ADVANCED REPRODUCTIVE TECHNOLOGY LTD.
  • TABLE 44: FERTILITY TREATMENT CENTER BUSINESS OVERVIEW
  • TABLE 45: SNAPSHOT OF FERTILITY TREATMENT CENTER
  • TABLE 46: FERTILITY TREATMENT CENTER BUSINESS OVERVIEW
  • TABLE 47: SNAPSHOT OF FERTILITY TREATMENT CENTER
  • TABLE 48: SUMMARY FOR IVF MARKET, MEXICO, 2010
  • TABLE 49: NUMBER OF IVF CYCLES, MEXICO, 2014 - 2021 (THOUSAND)
  • TABLE 50: MEXICO IVF MARKET 2014 - 2021 ($MILLION)
  • TABLE 51: MEXICO IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 52: MEXICO IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 53: LIV FERTILITY CENTER IN PUERTO VALLARTA BUSINESS OVERVIEW
  • TABLE 54: SNAPSHOT OF FERTILITY TREATMENT CENTER
  • TABLE 55: BIOFERTILITY CENTER IN GUDALAJARA BUSINESS OVERVIEW
  • TABLE 56: SNAPSHOT OF FERTILITY TREATMENT CENTER
  • TABLE 57: NUMBER OF IVF CYCLES, EUROPE, 2014 - 2021 (THOUSAND)
  • TABLE 58: EUROPE IVF MARKET 2014 - 2021 ($MILLION)
  • TABLE 59: NUMBER OF IVF CYCLES, GERMANY, 2014-2021 (THOUSAND)
  • TABLE 60: GERMANY IVF MARKET 2014-2021 ($MILLION)
  • TABLE 61: GERMANY IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 62: GERMANY IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 63: HEIDELBERG UNIVERSITY HOSPITAL BUSINESS OVERVIEW
  • TABLE 64: SNAPSHOT OF HEIDELBERG UNIVERSITY HOSPITAL
  • TABLE 65: KLINIKUM STUTTGART BUSINESS OVERVIEW
  • TABLE 66: COMPANY SNAPSHOT
  • TABLE 67: DRK KLINIKEN BERLIN BUSINESS OVERVIEW
  • TABLE 68: SNAPSHOT OF DRK KLINIKEN BERLIN
  • TABLE 69: UNIVERSITY MEDICAL CENTER FREIBURG BUSINESS OVERVIEW
  • TABLE 70: SNAPSHOT OF UNIVERSITY MEDICAL CENTER FREIBURG
  • TABLE 71: NUMBER OF IVF CYCLES, FRANCE, 2014-2021 (THOUSAND)
  • TABLE 72: FRANCE IVF MARKET 2014-2021 ($MILLION)
  • TABLE 73: FRANCE IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 74: FRANCE IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 75: CLINIQUE DE LA MUETTE BUSINESS OVERVIEW
  • TABLE 76: SNAPSHOT OF CLINIQUE DE LA MUETTE
  • TABLE 77: HOPITAL DES METALLURGISTS, HOPITAL COCHIN BUSINESS OVERVIEW
  • TABLE 78: SNAPSHOT OF HOPITAL DES METALLURGISTS, HOPITAL COCHIN
  • TABLE 79: IVF CYCLES BY VARIOUS AGE GROUPS, UNITED KINGDOM, 2011
  • TABLE 80: PROPORTION OF IVF CYCLES USING FRESH AND FROZEN EGGS, UNITED KINGDOM, 2010-2011
  • TABLE 81: IVF SUCCESS RATES IN UNITED KINGDOM (AS PER NHS), 2010
  • TABLE 82: REGIONAL IVF CLINICS AND TOTAL NUMBER OF WOMEN TREATED, UNITED KINGDOM, 2011
  • TABLE 83: UNITED KINGDOM IVF CYCLES, 2014-2021 (THOUSAND)
  • TABLE 84: UNITED KINGDOM IVF MARKET 2014-2021 ($MILLION)
  • TABLE 85: UNITED KINGDOM IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 86: UNITED KINGDOM IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 87: LISTER FERTILITY CLINIC BUSINESS OVERVIEW
  • TABLE 88: COMPANY SNAPSHOT
  • TABLE 89: THE BRIDGE CENTER BUSINESS OVERVIEW
  • TABLE 90: SNAPSHOT OF THE BRIDGE CENTER
  • TABLE 91: CHELSEA AND WESTMINSTER HOSPITAL BUSINESS OVERVIEW
  • TABLE 92: SNAPSHOT OF CHELSEA AND WESTMINSTER HOSPITAL
  • TABLE 93: ITALY IVF CYCLES, 2014-2021 (THOUSAND)
  • TABLE 94: ITALY IVF MARKET 2014-2021 ($MILLION)
  • TABLE 95: ITALY IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 96: ITALY IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 97: SPAIN IVF CYCLES, 2014-2021 (THOUSAND)
  • TABLE 98: SPAIN IVF MARKET 2014-2021 ($MILLION)
  • TABLE 99: SPAIN IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 100: SPAIN IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 101: DENMARK, IVF CYCLES, 2014-2021 (THOUSAND)
  • TABLE 102: DENMARK IVF MARKET 2014-2021 ($MILLION)
  • TABLE 103: DENMARK IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 104: DENMARK IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 105: RUSSIA IVF CYCLES, 2014-2021 (THOUSAND)
  • TABLE 106: RUSSIA IVF MARKET 2014-2021 ($MILLION)
  • TABLE 107: RUSSIA IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 108: RUSSIA IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 109: OTHER EUROPE IVF CYCLES, 2014-2021 (THOUSAND)
  • TABLE 110: OTHER EUROPE IVF MARKET 2014-2021 ($MILLION)
  • TABLE 111: OTHER EUROPE IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 112: OTHER EUROPE IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 113: NUMBER OF IVF CYCLES, ASIA-PACIFIC, 2014 - 2021 (THOUSAND)
  • TABLE 114: ASIA-PACIFIC IVF MARKET 2014 - 2021 ($MILLION)
  • TABLE 115: INDIA IVF CYCLES, 2014-2021 (THOUSAND)
  • TABLE 116: INDIA IVF MARKET 2014-2021 ($MILLION)
  • TABLE 117: INDIA IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 118: INDIA IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 119: SUN PHARMACEUTICAL BUSINESS OVERVIEW
  • TABLE 120: SNAPSHOT OF SUN PHARMACEUTICAL
  • TABLE 121: TRIVECTOR ORIGIO SCIENTIFIC BUSINESS OVERVIEW
  • TABLE 122: SNAPSHOT OF TRIVECTOR ORIGIO
  • TABLE 123: LAB IVF ASIA BUSINESS OVERVIEW
  • TABLE 124: SNAPSHOT OF LAB IVF ASIA
  • TABLE 125: LG LIFE SCIENCE BUSINESS OVERVIEW
  • TABLE 126: SNAPSHOT OF LG LIFE SCIENCE
  • TABLE 127: CADILA HEALTH CARE BUSINESS OVERVIEW
  • TABLE 128: SNAPSHOT OF CADILA HEALTH CARE
  • TABLE 129: BOURN HALL BUSINESS OVERVIEW
  • TABLE 130: SOUTHEND FERTILITY AND IVF CENTRE BUSINESS OVERVIEW
  • TABLE 131: MORPHEUS IVF FERTILITY CENTER BUSINESS OVERVIEW
  • TABLE 132: BLOOM FERTILITY CENTER BUSINESS OVERVIEW
  • TABLE 133: MANIPAL ANKUR BUSINESS OVERVIEW
  • TABLE 134: CLOUDNINE BUSINESS OVERVIEW
  • TABLE 135: NOVA IVI FERTILITY BUSINESS OVERVIEW
  • TABLE 136: CHINA IVF CYCLES, 2014-2021 (THOUSAND)
  • TABLE 137: CHINA IVF MARKET 2014-2021 ($MILLION)
  • TABLE 138: CHINA IVF CYCLES BY END USERS, 2014- 2021 (THOUSAND)
  • TABLE 139: CHINA IVF MARKET REVENUE BY END USERS, 2014- 2021 ($MILLION)
  • TABLE 140: COOK MEDICAL INC BUSINESS OVERVIEW
  • TABLE 141: SNAPSHOT OF COOK MEDICAL INC.
  • TABLE 142: VITROLIFE AB INC., BUSINESS OVERVIEW
  • TABLE 143: SNAPSHOT OF VITROLIFE AB INC.
  • TABLE 144: REPRODUCTIVE AND GENETIC HOSPITAL CITIC-XIANGYA, BUSINESS OVERVIEW
  • TABLE 145: SHENYANG HOSPITAL BUSINESS OVERVIE
  • TABLE 146: SHANDONG PROVINCIAL HOSPITAL BUSINESS OVERVIEW
  • TABLE 147: CENTRE FOR REPRODUCTIVE MEDICINE, BUSINESS OVERVIEW
  • TABLE 148: JAPAN IVF CYCLES, 2014-2021 (THOUSAND)
  • TABLE 149: JAPAN IVF MARKET 2014-2021 ($MILLION)
  • TABLE 150: JAPAN IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 151: JAPAN IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 152: EMD SERONO INC BUSINESS OVERVIEW
  • TABLE 153: SNAPSHOT OF EMD SERONO INC
  • TABLE 154: IVF NAMBA CLINIC BUSINESS OVERVIEW
  • TABLE 155: IWAKI WOMEN'S CLINIC BUSINESS OVERVIEW
  • TABLE 156: SANNO HOSPITAL BUSINESS OVERVIEW
  • TABLE 157: AUSTRALIA IVF CYCLES, 2014-2021 (THOUSAND)
  • TABLE 158: AUSTRALIA IVF MARKET 2014-2021 ($MILLION)
  • TABLE 159: OUTCOMES OF CYCLES OF IVF BY WOMEN'S AGE GROUP, 2011
  • TABLE 160: AUSTRALIA IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 161: AUSTRALIA IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 162: GENEA BIOMEDX TECHNOLOGIES BUSINESS OVERVIEW
  • TABLE 163: SNAPSHOT OF GENEA BIOMEDX TECHNOLOGIES
  • TABLE 164: SNAPSHOT OF THERMO FISHER SCIENTIFIC INC.
  • TABLE 165: THERMO FISHER SCIENTIFIC INC. BUSINESS OVERVIEW
  • TABLE 166: VIRTUS HEALTH BUSINESS OVERVIEW
  • TABLE 167: MONASH IVF BUSINESS OVERVIEW
  • TABLE 168: CITY FERTILITY BUSINESS OVERVIEW
  • TABLE 169: FLINDERS FERTILITY BUSINESS OVERVIEW
  • TABLE 170: NEW ZEALAND IVF CYCLES, 2014-2021 (THOUSAND)
  • TABLE 171: NEW ZEALAND IVF MARKET 2014-2021 ($MILLION)
  • TABLE 172: NEW ZEALAND IVF REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 173: NEW ZEALAND IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 174: KOREA IVF CYCLES, 2014-2021 (THOUSAND)
  • TABLE 175: NEW ZEALAND IVF MARKET 2014-2021 ($MILLION)
  • TABLE 176: KOREA IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 177: KOREA IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 178: THAILAND IVF CYCLES, 2014-2021 (THOUSAND)
  • TABLE 179: THAILAND IVF MARKET 2014-2021 ($MILLION)
  • TABLE 180: THAILAND IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 181: THAILAND IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 182: OTHER ASIA-PACIFIC IVF CYCLES, 2014-2021 (THOUSAND)
  • TABLE 183: OTHER ASIA-PACIFIC IVF MARKET 2014-2021 ($MILLION)
  • TABLE 184: OTHER ASIA-PACIFIC IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 185: OTHER ASIA-PACIFIC IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 186: LAMEA IVF CYCLES, 2014 - 2021 (THOUSAND)
  • TABLE 187: LAMEA IVF MARKET 2014 - 2021 ($MILLION)
  • TABLE 188: LATIN AMERICA IVF CYCLES, 2014-2021 (THOUSAND)
  • TABLE 189: LATIN AMERICA IVF MARKET 2014-2021 ($MILLION)
  • TABLE 190: LATIN AMERICA IVF CYCLES BY END USERS, 2014- 2021 (THOUSAND)
  • TABLE 191: LATIN AMERICA IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 192: CLINICA ANGLO AMERICANA BUSINESS OVERVIEW
  • TABLE 193: SNAPSHOT OF CLINICA ANGLO AMERICANA
  • TABLE 194: IVF PANAMA CENTRO DE REPRODUCCION PUNTA PACIFICA BUSINESS OVERVIEW
  • TABLE 195: SNAPSHOT OF IVF PANAMA CENTRO DE REPRODUCCION PUNTA PACIFICA
  • TABLE 196: INSAMER BUSINESS OVERVIEW
  • TABLE 197: COMPANY SNAPSHOT
  • TABLE 198: ALMATER HOSPITAL BUSINESS OVERVIEW
  • TABLE 199: COMPANY SNAPSHOT
  • TABLE 200: SAN FERNANDO HOSPITAL BUSINESS OVERVIEW
  • TABLE 201: COMPANY SNAPSHOT
  • TABLE 202: MIDDLE EAST IVF CYCLES, 2014-2021 (THOUSAND)
  • TABLE 203: MIDDLE EAST IVF MARKET 2014-2021 ($MILLION)
  • TABLE 204: MIDDLE EAST IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 205: MIDDLE EAST IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 206: CYPRUS IVF CENTRE BUSINESS OVERVIEW
  • TABLE 207: COMPANY SNAPSHOT
  • TABLE 208: AL BUSHRA MEDICAL SPECIALTY COMPLEX BUSINESS OVERVIEW
  • TABLE 209: COMPANY OF AL BUSHRA MEDICAL SPECIALTY COMPLEX
  • TABLE 210: REPRODUCTIVE MEDICINE UNIT AT CORNICHE HOSPITAL BUSINESS OVERVIEW
  • TABLE 211: SNAPSHOT OF REPRODUCTIVE MEDICINE UNIT AT CORNICHE HOSPITAL
  • TABLE 212: TRAKYA UNIVERSITY HOSPITAL ART CENTER BUSINESS OVERVIEW
  • TABLE 213: SNAPSHOT OF TRAKYA UNIVERSITY HOSPITAL ART CENTER
  • TABLE 214: AFRICA IVF CYCLES, 2014-2021 (THOUSAND)
  • TABLE 215: AFRICA IVF MARKET 2014-2021 ($MILLION)
  • TABLE 216: AFRICA IVF CYCLES BY END USERS, 2014 - 2021 (THOUSAND)
  • TABLE 217: AFRICA IVF MARKET REVENUE BY END USERS, 2014 - 2021 ($MILLION)
  • TABLE 218: LIFESURE FERTILITY & GYNAECOLOGY CENTRE BUSINESS OVERVIEW
  • TABLE 219: COMPANY SNAPSHOT
  • TABLE 220: BETHANY WOMEN AND FAMILY HOSPITAL BUSINESS OVERVIEW
  • TABLE 221: COMPANY SNAPSHOT
  • TABLE 222: BIOART FERTILITY CENTRE BUSINESS OVERVIEW
  • TABLE 223: COMPANY SNAPSHOT
  • TABLE 224: DEL INTERNATIONAL HOSPITAL & FERTILITY CENTRE BUSINESS OVERVIEW
  • TABLE 225: COMPANY SNAPSHOT
  • TABLE 226: GIFT OV LIFE BUSINESS OVERVIEW
  • TABLE 227: COMPANY SNAPSHOT
  • TABLE 228: DURBAN FERTILITY CLINIC BUSINESS OVERVIEW
  • TABLE 229: COMPANY SNAPSHOT
  • TABLE 230: CAPE FERTILITY CLINIC BUSINESS OVERVIEW
  • TABLE 231: COMPANY SNAPSHOT

List of Figures

  • FIG. 1: GLOBAL IVF MARKET, 2014 - 2021 ($MILLION)
  • FIG. 2: NUMBER OF GLOBAL IVF CYCLES, 2014 - 2021 (THOUSAND)
  • FIG. 3: REGULATORY SCENARIO, UNITED STATES
  • FIG. 4: REGULATORY SCENARIO, CANADA
  • FIG. 5: REGULATORY SCENARIO, MEXICO
  • FIG. 6: REGULATORY SCENARIO, GERMANY
  • FIG. 7: REGULATORY SCENARIO, FRANCE
  • FIG. 8: REGULATORY SCENARIO, UNITED KINGDOM
  • FIG. 9: TOTAL FERTILITY RATE ( CHILDREN BORN/ WOMEN)
  • FIG. 10: CHINA FERTILITY RATE (CHILDREN BORN/WOMEN)
  • FIG. 11: TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)
  • FIG. 12: TOTAL FERTILITY RATE ( CHILDREN BORN/ WOMEN)
  • FIG. 13: IVF SUCCESS RATE FOR AUSTRALIA
  • FIG. 14: TOTAL FERTILITY RATE ( CHILDREN BORN/ WOMEN)
  • FIG. 15: TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN) - SOUTH KOREA
  • FIG. 16: THAILAND FERTILITY RATE CHILD BORN/WOMEN
  • FIG. 17: REGULATORY SCENARIO, LATIN AMERICA
  • FIG. 18: EGULATORY SCENARIO, MIDDLE EAST
  • FIG. 19: REGULATORY SCENARIO, AFRICA
Back to Top